180 related articles for article (PubMed ID: 38315789)
1. Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non-Small Cell Lung Cancer.
Rigamonti A; Viatore M; Polidori R; Rahal D; Erreni M; Fumagalli MR; Zanini D; Doni A; Putignano AR; Bossi P; Voulaz E; Alloisio M; Rossi S; Zucali PA; Santoro A; Balzano V; Nisticò P; Feuerhake F; Mantovani A; Locati M; Marchesi F
Cancer Res; 2024 Apr; 84(7):1165-1177. PubMed ID: 38315789
[TBL] [Abstract][Full Text] [Related]
2. Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab.
Baxi V; Lee G; Duan C; Pandya D; Cohen DN; Edwards R; Chang H; Li J; Elliott H; Pokkalla H; Glass B; Agrawal N; Lahiri A; Wang D; Khosla A; Wapinski I; Beck A; Montalto M
Mod Pathol; 2022 Nov; 35(11):1529-1539. PubMed ID: 35840720
[TBL] [Abstract][Full Text] [Related]
3. Automated annotations of epithelial cells and stroma in hematoxylin-eosin-stained whole-slide images using cytokeratin re-staining.
Brázdil T; Gallo M; Nenutil R; Kubanda A; Toufar M; Holub P
J Pathol Clin Res; 2022 Mar; 8(2):129-142. PubMed ID: 34716754
[TBL] [Abstract][Full Text] [Related]
4. Applications of Artificial Intelligence in Lung Pathology.
Hartman DJ
Surg Pathol Clin; 2024 Jun; 17(2):321-328. PubMed ID: 38692814
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence-powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non-small cell lung cancer with better prediction of immunotherapy response.
Choi S; Cho SI; Ma M; Park S; Pereira S; Aum BJ; Shin S; Paeng K; Yoo D; Jung W; Ock CY; Lee SH; Choi YL; Chung JH; Mok TS; Kim H; Kim S
Eur J Cancer; 2022 Jul; 170():17-26. PubMed ID: 35576849
[TBL] [Abstract][Full Text] [Related]
6. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
7. Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer.
Park S; Ock CY; Kim H; Pereira S; Park S; Ma M; Choi S; Kim S; Shin S; Aum BJ; Paeng K; Yoo D; Cha H; Park S; Suh KJ; Jung HA; Kim SH; Kim YJ; Sun JM; Chung JH; Ahn JS; Ahn MJ; Lee JS; Park K; Song SY; Bang YJ; Choi YL; Mok TS; Lee SH
J Clin Oncol; 2022 Jun; 40(17):1916-1928. PubMed ID: 35271299
[TBL] [Abstract][Full Text] [Related]
8. Spatial metabolomics for evaluating response to neoadjuvant therapy in non-small cell lung cancer patients.
Shen J; Sun N; Zens P; Kunzke T; Buck A; Prade VM; Wang J; Wang Q; Hu R; Feuchtinger A; Berezowska S; Walch A
Cancer Commun (Lond); 2022 Jun; 42(6):517-535. PubMed ID: 35593195
[TBL] [Abstract][Full Text] [Related]
9. Artificial Intelligence-Aided Diagnosis of Breast Cancer Lymph Node Metastasis on Histologic Slides in a Digital Workflow.
Challa B; Tahir M; Hu Y; Kellough D; Lujan G; Sun S; Parwani AV; Li Z
Mod Pathol; 2023 Aug; 36(8):100216. PubMed ID: 37178923
[TBL] [Abstract][Full Text] [Related]
10. Using Artificial Intelligence to Identify Tumor Microenvironment Heterogeneity in Non-Small Cell Lung Cancers.
DuCote TJ; Naughton KJ; Skaggs EM; Bocklage TJ; Allison DB; Brainson CF
Lab Invest; 2023 Aug; 103(8):100176. PubMed ID: 37182840
[TBL] [Abstract][Full Text] [Related]
11. Robust subtyping of non-small cell lung cancer whole sections through MALDI mass spectrometry imaging.
Janßen C; Boskamp T; Hauberg-Lotte L; Behrmann J; Deininger SO; Kriegsmann M; Kriegsmann K; Steinbuß G; Winter H; Muley T; Casadonte R; Kriegsmann J; Maaß P
Proteomics Clin Appl; 2022 Jul; 16(4):e2100068. PubMed ID: 35238465
[TBL] [Abstract][Full Text] [Related]
12. Feature-driven local cell graph (FLocK): New computational pathology-based descriptors for prognosis of lung cancer and HPV status of oropharyngeal cancers.
Lu C; Koyuncu C; Corredor G; Prasanna P; Leo P; Wang X; Janowczyk A; Bera K; Lewis J; Velcheti V; Madabhushi A
Med Image Anal; 2021 Feb; 68():101903. PubMed ID: 33352373
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers.
Wakabayashi O; Yamazaki K; Oizumi S; Hommura F; Kinoshita I; Ogura S; Dosaka-Akita H; Nishimura M
Cancer Sci; 2003 Nov; 94(11):1003-9. PubMed ID: 14611679
[TBL] [Abstract][Full Text] [Related]
14. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
Zhu ZH; Sun BY; Ma Y; Shao JY; Long H; Zhang X; Fu JH; Zhang LJ; Su XD; Wu QL; Ling P; Chen M; Xie ZM; Hu Y; Rong TH
J Clin Oncol; 2009 Mar; 27(7):1091-9. PubMed ID: 19188679
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.
Luo X; Zang X; Yang L; Huang J; Liang F; Rodriguez-Canales J; Wistuba II; Gazdar A; Xie Y; Xiao G
J Thorac Oncol; 2017 Mar; 12(3):501-509. PubMed ID: 27826035
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors.
Park C; Jeong DY; Choi Y; Oh YJ; Kim J; Ryu J; Paeng K; Lee SH; Ock CY; Lee HY
Front Immunol; 2022; 13():1038089. PubMed ID: 36660547
[TBL] [Abstract][Full Text] [Related]
17. Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment.
Mitchell D; Hunt AL; Conrads KA; Hood BL; Makohon-Moore SC; Rojas C; Maxwell GL; Bateman NW; Conrads TP
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35723500
[TBL] [Abstract][Full Text] [Related]
18. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
[TBL] [Abstract][Full Text] [Related]
19. Digital Pathology for Better Clinical Practice.
Hijazi A; Bifulco C; Baldin P; Galon J
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730638
[TBL] [Abstract][Full Text] [Related]
20. A Review of Artificial Intelligence in Precise Assessment of Programmed Cell Death-ligand 1 and Tumor-infiltrating Lymphocytes in Non-Small Cell Lung Cancer.
Wu J; Lin D
Adv Anat Pathol; 2021 Nov; 28(6):439-445. PubMed ID: 34623343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
